(PDF) One-Year Effectiveness and Safety of Vedolizumab

One-Year Effectiveness and Safety of Vedolizumab Therapy for Inflammatory Bowel Disease: A Prospective Multicentre Cohort Study

Alimentary Pharmacology and Therapeutics - United Kingdom

doi 10.1111/apt.14167

Full Text

Abstract

Available in full text

Categories

Gastroenterology

Date

June 8, 2017

Authors

L. Peyrin-Biroulet

C. Trang-Poisson

A.-L. Pelletier

Publisher

Wiley

Related search

Early Vedolizumab Trough Levels Predict Mucosal Healing in Inflammatory Bowel Disease: A Multicentre Prospective Observational Study

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease

Digestive Diseases and Sciences

Gastroenterology

English

Diagnostic Accuracy of Fecal Calprotectin for Pediatric Inflammatory Bowel Disease in Primary Care: A Prospective Cohort Study

Annals of Family Medicine

Family Practice

English

Letter: Vedolizumab for Autoimmune Liver Disease Associated Inflammatory Bowel Disease-Authors’ Reply

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Rhythmical Massage Therapy in Chronic Disease: A 4-Year Prospective Cohort Study

Journal of Alternative and Complementary Medicine

Alternative Medicine

English

Anthroposophic Medical Therapy in Chronic Disease: A Four-Year Prospective Cohort Study

BMC Complementary and Alternative Medicine

Alternative Medicine

English

Vedolizumab for Inflammatory Bowel Disease: Changing the Game, or More of the Same?

United European Gastroenterology Journal

Gastroenterology

English

Review Article: Predictors of Response to Vedolizumab and Ustekinumab in Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Anthroposophic Therapy for Children With Chronic Disease: A Two-Year Prospective Cohort Study in Routine Outpatient Settings

English